Why the study?
Does dipyridamole potentiate adenosine-mediated or nitric oxide-mediated vasodilation in normal volunteers?
Population
13 normal volunteers (6 in a 7-day study, 7 in a single-dose study)
Comparison
Dipyridamole/aspirin for 7 days or as a single… vs Aspirin alone or baseline before treatment
Design
RCT, Vasodilators administered in random order, Double-blind
Follow-up
7 days or 2 hours
Authors
Loading...
Confirms dipyridamole potentiates adenosine- but not NO-mediated vasodilation; extends mechanistic basis for its cerebrovascular use.
Does dipyridamole potentiate adenosine-mediated or nitric oxide-mediated vasodilation in normal volunteers?
Dipyridamole's vascular effects are primarily mediated by the potentiation of adenosine rather than nitric oxide or cGMP pathways.
Gamboa et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: